New research has found that through the use of minimally-invasive techniques, it is possible to see if a person has Alzheimer's disease or not.
Teams at McGill University and the Lady Davis Institute for Medical Research (LDI) at the Jewish General Hospital in Montreal found that by using infra-red technology, scientists can identify a chemical signature which can distinguish Alzheimer's disease from regular aging.
Hyman Schipper, the lead author of the report, said of the findings: "There is an urgent need for an accurate diagnostic test to aid in the early diagnosis and management of Alzheimer's disease.
"Our observations give us hope that biospectroscopy will offer a new approach to the early diagnosis of Alzheimer's disease and other neurodegenerative disorders."
The charitable work to support Alzheimer's disease continues to go from strength to strength in the UK, with the Alzheimer's Society announcing that a band with ties to the condition - Trouble with Tuesday - will be performing a charity gig in Milton Keynes at the end of August.
Please click here for advice to help you find the right type of care.